Contact information
Jennifer Williams
BSc (Hons), PhD
Senior Clinical Research Manager
I am based within the Experimental Medicine and Rheumatology group of OCTRU. I facilitate clinical translation within the Kennedy Institute of Rheumatology by working with Principal Investigators to develop proposals for new experimental medicine studies and clinical trials. I also support the existing trial portfolio within the Kennedy Institute.
I joined NDORMS in 2018 as a trial manager working on experimental medicine and rheumatology studies, HOPE-e, RAMBOH-1 and VROOM.
Prior to joining NDORMS I was part of the NIHR Clinical Research Network facilitating the set-up and running of several commercial CTIMPs.
Before moving into the field of clinical trials, I was a scientist working in lab-based research for over 10 years. I gained my BSc (Hons) from the University of Birmingham after which I moved to London and gained my PhD in Cell Biology from UCL Institute of Ophthalmology. The majority of my publications focus on the role of the complement system in age-related macular degeneration.
Recent publications
Temporary 2-week suspension of methotrexate treatment to enhance COVID-19 vaccine response in people with immune-mediated inflammatory diseases: the VROOM RCT
Journal article
Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 1 - 42
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
Journal article
Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 12, 47 - 48
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Journal article
Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 12, 45 - 46
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
Journal article
Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 12, 43 - 44
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Journal article
Abhishek A. et al, (2024), Lancet Rheumatol, 6, e92 - e104